MIST
Milestone Pharmaceuticals Inc.
$1.92
+1.59%
2026-05-08
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Key Fundamentals
Forward P/E
-2.09
EPS (TTM)
$-0.75
ROE
-229.7%
Profit Margin
0.0%
Debt/Equity
139.76
Price/Book
5.56
Beta
1.04
Market Cap
$226.7M
Avg Volume (10D)
871K
Recent Breakout Signals
No recent breakout signals detected for MIST.
Recent Price Range (60 Days)
60D High
$2.34
60D Low
$1.00
Avg Volume
2.0M
Latest Close
$1.92
Get breakout alerts for MIST
Sign up for Breakout Scanner to receive daily notifications when MIST triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Milestone Pharmaceuticals Inc. (MIST) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors MIST daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. MIST operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.